- Home
- KRYS vs RLX Comparison
KRYS vs RLX Comparison
Compare KRYS & RLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- RLX
- Stock Information
- Founded
- KRYS 2015
- RLX 2018
- Country
- KRYS United States
- RLX China
- Employees
- KRYS N/A
- RLX N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- RLX Medicinal Chemicals and Botanical Products
- Sector
- KRYS Health Care
- RLX Health Care
- Exchange
- KRYS Nasdaq
- RLX Nasdaq
- Market Cap
- KRYS 4.6B
- RLX 3.7B
- IPO Year
- KRYS 2017
- RLX 2021
- Fundamental
- Price
- KRYS $187.96
- RLX $2.43
- Analyst Decision
- KRYS Strong Buy
- RLX Strong Buy
- Analyst Count
- KRYS 7
- RLX 1
- Target Price
- KRYS $210.00
- RLX $2.76
- AVG Volume (30 Days)
- KRYS 245.3K
- RLX 4.8M
- Earning Date
- KRYS 02-19-2025
- RLX 03-14-2025
- Dividend Yield
- KRYS N/A
- RLX 0.33%
- EPS Growth
- KRYS 669.23
- RLX 607.62
- EPS
- KRYS 3.00
- RLX 0.07
- Revenue
- KRYS $290,515,000.00
- RLX $307,798,132.00
- Revenue This Year
- KRYS $483.09
- RLX $117.52
- Revenue Next Year
- KRYS $57.70
- RLX $42.76
- P/E Ratio
- KRYS $62.62
- RLX $32.89
- Revenue Growth
- KRYS 473.02
- RLX 99.79
- 52 Week Low
- KRYS $109.57
- RLX $1.50
- 52 Week High
- KRYS $219.34
- RLX $2.69
- Technical
- Relative Strength Index (RSI)
- KRYS 73.39
- RLX 63.09
- Support Level
- KRYS $148.00
- RLX $2.29
- Resistance Level
- KRYS $190.00
- RLX $2.45
- Average True Range (ATR)
- KRYS 7.31
- RLX 0.12
- MACD
- KRYS 3.66
- RLX -0.00
- Stochastic Oscillator
- KRYS 93.87
- RLX 50.00
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About RLX RLX Technology Inc. each representing the right to receive one (1) ordinary share
RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market.